找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Metronomic Chemotherapy; Pharmacology and Cli Guido Bocci,Giulio Francia Book 2014 The Editor(s) (if applicable) and The Author(s), under e

[复制链接]
楼主: 侧面上下
发表于 2025-3-26 22:48:24 | 显示全部楼层
发表于 2025-3-27 02:13:09 | 显示全部楼层
Lisa Salvatore,Federica Zoratto,Fotios Loupakis,Alfredo Falconerliegende Beitrag untersucht die Validität der darauf aufbauenden Messinstrumente am Beispiel des T.-M.s. Mithilfe dieser einzigartigen Längsschnittstudie werden für einen Zeitraum von zwei Jahrzehnten die interne Struktur und Entwicklung der Messung und des Phänomens ‚Rechtsextremismus‘ analysiert.
发表于 2025-3-27 09:14:20 | 显示全部楼层
发表于 2025-3-27 13:11:20 | 显示全部楼层
https://doi.org/10.1007/978-3-662-43604-2Antiangiogenic drugs; Cancer; Metronomic chemotherapy; Pharmacology
发表于 2025-3-27 16:25:23 | 显示全部楼层
Guido Bocci,Giulio FranciaCovers all aspects of metronomic chemotherapy.Describes the pharmacological bases of metronomic chemotherapy.Presents and discusses the clinical results of all published studies on metronomic chemothe
发表于 2025-3-27 18:14:01 | 显示全部楼层
发表于 2025-3-27 22:36:15 | 显示全部楼层
发表于 2025-3-28 03:43:49 | 显示全部楼层
The Role of Metronomic Chemotherapy in the Treatment of Metastatic Colorectal Cancer Patients or partial antiangiogenic activity such as bevacizumab, aflibercept, and regorafenib. Metronomic chemotherapy may be an alternative strategy for targeting tumor angiogenesis and several clinical studies suggested its promising activity and its extremely favorable toxicity profile in the treatment of metastatic colorectal cancer patients.
发表于 2025-3-28 07:17:17 | 显示全部楼层
Mechanisms of Action of Low-Dose Metronomic Chemotherapyction. Initially, LDM was considered an antiangiogenic treatment strategy; however, in the last decade additional preclinical studies uncovered other possible mechanisms including enhancing the antitumor immune response, substantially increasing the efficacy of targeted drugs by various mechanisms,
发表于 2025-3-28 13:28:53 | 显示全部楼层
Effects of Metronomic Chemotherapy on Immunity-bearing hosts. However, administration protocols heavily influence the host’s immunity because chemotherapeutic agents potentially kill proliferating lymphocytes. To this end, we investigated the effects of a CTX administration protocol on the in vivo induction of antitumor T cells in a preclinical
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-7 15:15
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表